Immutable evidence record · ticker
Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Published as observed on 20 August 2026 at 03:13 BST.
Telomir Pharmaceuticals, Inc. Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 20 Aug 2026, 03:13
- Scope
- company and instrument
- Evidence
- 21 items
- Independent sources
- 3
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Telomir Pharmaceuticals, Inc. Common Stock (TELO), 2026-08-20, https://sharemaestro.com/evidence/fc271e85-0426-4af4-af74-20adc3a8a2f3/
Record checksum 77011868bd15e1989991d80e645a1f32dc26609b50fc1fd8b60ca594d7116121
